Literature DB >> 12928019

Quantitative analysis of dobutamine-atropine stress echocardiography.

S Carstensen1, U Høst, K Saunamäki, H Kelbaek.   

Abstract

AIMS: To investigate the usefulness of fractional area change of entire left ventricular areas obtained from apical views for quantitative analysis of dobutamine-atropine stress echocardiography in the presence of mild to moderately reduced left ventricular function and abnormal intra-thoracic heart motion after coronary artery bypass surgery. METHODS AND
RESULTS: Stress echocardiograms from 38 echogenic patients before and 3 months after bypass surgery and from 44 echogenic healthy subjects were analysed. In successfully revascularized patients the fractional area change at peak stress was correlated to the baseline left ventricular ejection fraction (r=0.54, P<0.01), whereas the increase from baseline to peak stress was constant over a wide range of baseline ejection fractions. With respect to identifying the pre-revascularization examination as diseased, the area under the receiver operator characteristics curve based on Delta fractional area change from baseline to peak stress was 0.78 (95% CI 0.55-1.00) indicating moderate accuracy comparable with the results obtained with conventional analysis.
CONCLUSION: Fractional area change of entire left ventricular cavity areas is a useful parameter for quantitative analysis of dobutamine-atropine stress echocardiography. The diagnostic properties of the parameter are not offset by moderate reduction in left ventricular function or by surgery-induced abnormal intra-thoracic heart motion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928019     DOI: 10.1016/s1525-2167(02)00161-0

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  1 in total

1.  Use of atropine in patients with recent myocardial infarction during exercise myocardial perfusion study. Use of atropine during exercise myocardial perfusion SPECT.

Authors:  S Barai; C D Patel; A Malhotra; G P Bandopadhayaya; S Gambhir; R Kumar; H Dhanapathi
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.